/study / lectures / Crisis Management
Methemoglobinemia — Causes, Recognition, Methylene Blue Treatment
TEXTCrisis Management · 6 min read
Chocolate-brown blood, a pulse ox stuck at 85%, and a patient who just got benzocaine spray. The classic anesthesia presentation + the methylene-blue answer — with the G6PD trap.
After this lesson you can
2 min read6 sectionsPathophysiology
Oxidant stress converts iron to ferric (Fe³⁺) — methemoglobin — which CANNOT bind O₂ and also left-shifts the dissociation curve of any remaining normal Hb, impairing tissue O₂ release.
Normal MetHb <1% (kept low by NADH-cytochrome-b5-reductase).
Symptoms appear ~15-20% MetHb (cyanosis), serious hypoxia >30%, lethal >70%.
The cellular picture is cyanide-like: oxygen present in blood but unavailable to tissues.
Etiology — the anesthesia-relevant culprits
EMLA cream + prilocaine in infants <3 mo (immature reductase).
Dapsone (PCP prophylaxis in HIV, leprosy, dermatology) — chronic + dose-dependent.
Topical nitrates, nitroglycerin in neonates, amyl/butyl nitrite (poppers, recreational).
Nitric oxide therapy.
Aniline dyes, sulfonamides, phenazopyridine.
Well-water nitrates in infants.
Congenital methemoglobinemia (rare — cytochrome-b5-reductase deficiency, HbM variants).
Clinical + the pulse-ox trap
Chocolate-brown arterial blood that doesn't pink up on O₂ exposure (classic — show the syringe to a colleague).
Dyspnea, tachycardia, headache, confusion, seizure, coma at higher levels.
The pulse-ox pearl: with rising MetHb, SpO₂ falls toward ~85% and then PLATEAUS regardless of true SaO₂.
This is because at higher MetHb levels, pulse ox (which uses red 660 nm + IR 940 nm) interprets the absorbance ratio as ~85%.
SpO₂ of 85% on supplemental O₂ that doesn't improve = methemoglobinemia until proven otherwise.
Diagnosis
A 'normal' ABG PaO₂ with a low SaO₂ on co-ox is the giveaway (PaO₂ measures dissolved O₂, unaffected by MetHb; SaO₂ on co-ox is true).
Routine pulse oximetry is NOT reliable.
- lactate (rises in severe)
- troponin (cellular hypoxia stress)
- CBC
- BMP
Treatment — methylene blue + the G6PD caveat
100% O₂ (improves dissolved O₂ transport, doesn't directly reduce MetHb).
Methylene blue 1-2 mg/kg IV over 5 min — accepts electrons from NADPH-methemoglobin reductase to reduce Fe³⁺ back to Fe²⁺; works within 30-60 min.
Indicated for MetHb >25% symptomatic, or >30% asymptomatic, or any level with cardiovascular/neurological compromise.
Repeat dose at 1 hr if needed; total <7 mg/kg (above this, methylene blue itself causes MetHb).
Use ascorbic acid 1.5 g IV q4h, or exchange transfusion, or hyperbaric O₂ in G6PD-deficient or severe cases.
Prevention + disposition
Infants <3 mo: avoid prilocaine + EMLA on large areas.
Dapsone patients: counsel about cumulative risk + screen MetHb if symptomatic.
Post-treatment: monitor 4-6 hours for rebound (especially with dapsone — long half-life), recheck co-oximetry q1-2h until clearly resolving.
Document on the chart + medical alert + family history if any congenital variant suspected.
End of lecture
You just covered ~2 minutes of Crisis Management. Reinforce with a few questions while it's fresh.